Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity

References

• Ruzek D, Avšič Županc T, Borde J, et al. Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 2019;164:23–51. doi:10.1016/j.antiviral.2019.01.014
   PubMed Web of Science ®Google Scholar
• Kubinski M, Beicht J, Gerlach T, et al. Tick-Borne encephalitis virus: A quest for better vaccines against a virus on the rise. Vaccines (Basel). 2020;8(3):451.
   PubMed Web of Science ®Google Scholar
• Friedsam AM, Brady OJ, Pilic A, et al. Geo-Spatial characteristics of 567 places of tick-borne encephalitis infection in southern Germany, 2018-2020. Microorganisms. 2022;10(3):643.
   PubMed Web of Science ®Google Scholar
• Süss J, Schrader C, Falk U, et al. Tick-borne encephalitis (TBE) in Germany–epidemiological data, development of risk areas and virus prevalence in field-collected ticks and in ticks removed from humans. Int J Med Microbiol. 2004;293(Suppl 37):69–79.
   PubMedGoogle Scholar
• Steffen R. Tick-borne encephalitis (TBE) in children in Europe: epidemiology, clinical outcome and comparison of vaccination recommendations. Ticks Tick Borne Dis. 2019;10(1):100–110. doi:10.1016/j.ttbdis.2018.08.003
   PubMed Web of Science ®Google Scholar
• Bogovič P, Lotrič-Furlan S, Avšič-Županc T, et al. Low virus-specific IgG antibodies in adverse clinical course and outcome of tick-borne encephalitis. Microorganisms. 2021;9(2):332.
   PubMed Web of Science ®Google Scholar
• Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis–correlation with clinical outcome. Infection. 2000 Mar-Apr;28(2):78–84. doi:10.1007/s150100050051
   PubMed Web of Science ®Google Scholar
• Kohlmaier B, Schweintzger NA, Sagmeister MG, et al. Clinical characteristics of patients with tick-borne encephalitis (TBE): A European multicentre study from 2010 to 2017. Microorganisms. 2021;9(7):1420.
   PubMed Web of Science ®Google Scholar
• Bogovič P, Stupica D, Rojko T, et al. The long-term outcome of tick-borne encephalitis in central Europe. Ticks Tick Borne Dis. 2018;9(2):369–378. doi:10.1016/j.ttbdis.2017.12.001
   PubMed Web of Science ®Google Scholar
• Hansson KE, Rosdahl A, Insulander M, et al. Tick-borne encephalitis vaccine failures: A 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at Age 50 years. Clin Infect Dis. 2020;70(2):245–251. doi:10.1093/cid/ciz176
   PubMed Web of Science ®Google Scholar
• Dobler G, Kaier K, Hehn P, et al. Tick-borne encephalitis virus vaccination breakthrough infections in Germany: a retrospective analysis from 2001 to 2018. Clin Microbiol Infect. 2020;26(8):1090.e7–1090.e13.
   PubMed Web of Science ®Google Scholar
• Blom K, Braun M, Pakalniene J, et al. Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLoS Pathog. 2015;11(1):e1004622. doi:10.1371/journal.ppat.1004622
   PubMed Web of Science ®Google Scholar
• Beicht J, Kubinski M, Zdora I, et al. Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Front Immunol. 2023;14:1177324. doi:10.3389/fimmu.2023.1177324
   PubMed Web of Science ®Google Scholar
• Salat J, Mikulasek K, Larralde O, et al. Tick-Borne encephalitis virus vaccines contain Non-structural protein 1 antigen and may elicit NS1-specific antibody responses in vaccinated individuals. Vaccines (Basel). 2020;8(1):81.
   PubMed Web of Science ®Google Scholar
• Bogovic P, Logar M, Avsic-Zupanc T, et al. Quantitative evaluation of the severity of acute illness in adult patients with tick-borne encephalitis. Biomed Res Int. 2014;2014:841027.
   PubMed Web of Science ®Google Scholar
• Turtle L, Bali T, Buxton G, et al. Human T cell responses to Japanese encephalitis virus in health and disease. J Exp Med. 2016;213(7):1331–1352. doi:10.1084/jem.20151517
   PubMed Web of Science ®Google Scholar
• Petry M, Palus M, Leitzen E, et al. Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but Not from TBEV entry into the CNS. Vaccines (Basel). 2021;9(3):196.
   PubMed Web of Science ®Google Scholar
• Kubinski M, Beicht J, Zdora I, et al. A recombinant modified vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. Front Immunol. 2023;14:1182963. doi:10.3389/fimmu.2023.1177324
   PubMed Web of Science ®Google Scholar
• Agudelo M, Palus M, Keeffe JR, et al. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease. J Exp Med. 2021;218(5):e20210236.
   PubMed Web of Science ®Google Scholar
• Baykov IK, Matveev AL, Stronin OV, et al. A protective chimeric antibody to tick-borne encephalitis virus. Vaccine. 2014;32(29):3589–3594. doi:10.1016/j.vaccine.2014.05.012
   PubMed Web of Science ®Google Scholar
• Levanov LN, Matveev LE, Goncharova EP, et al. Chimeric antibodies against tick-borne encephalitis virus. Vaccine. 2010;28(32):5265–5271. doi:10.1016/j.vaccine.2010.05.060
   PubMed Web of Science ®Google Scholar
• Mickiene A, Laiskonis A, Günther G, et al. Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis. 2002 Sep 15;35(6):650–658. doi:10.1086/342059
   PubMed Web of Science ®Google Scholar
• Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain. 1999 Nov;122:2067–2078. doi:10.1093/brain/122.11.2067
   PubMed Web of Science ®Google Scholar
• Bogovič P, Lotrič-Furlan S, Avšič-Županc T, et al. Factors associated with severity of tick-borne encephalitis: A prospective observational study. Travel Med Infect Dis. 2018;26:25–31.
   PubMed Web of Science ®Google Scholar
• Lampen MH, Uchtenhagen H, Blom K, et al. Breadth and dynamics of HLA-A2- and HLA-B7-restricted CD8(+) T cell responses against nonstructural viral proteins in acute human tick-borne encephalitis virus infection. Immunohorizons. 2018;2(6):172–184.
   PubMedGoogle Scholar
• Gelpi E, Preusser M, Laggner U, et al. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue. J Neurovirol. 2006;12(4):322–327. doi:10.1080/13550280600848746
   PubMed Web of Science ®Google Scholar
• Gelpi E, Preusser M, Garzuly F, et al. Visualization of central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol. 2005;64(6):506–512. doi:10.1093/jnen/64.6.506
   PubMed Web of Science ®Google Scholar
• Johnson RT, Burke DS, Elwell M, et al. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol. 1985;18(5):567–573. doi:10.1002/ana.410180510
   PubMed Web of Science ®Google Scholar
• Fujii Y, Hayasaka D, Kitaura K, et al. T-cell clones expressing different T-cell receptors accumulate in the brains of dying and surviving mice after peripheral infection with far eastern strain of tick-borne encephalitis virus. Viral Immunol. 2011;24(4):291–302. doi:10.1089/vim.2011.0017
   PubMed Web of Science ®Google Scholar
• Hayasaka D, Nagata N, Fujii Y, et al. Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses. Virology. 2009;390(1):139–150. doi:10.1016/j.virol.2009.04.026
   PubMed Web of Science ®Google Scholar
• Aberle JH, Schwaiger J, Aberle SW, et al. Human CD4+ T helper cell responses after tick-borne encephalitis vaccination and infection. PLoS One. 2015;10(10):e0140545.
   PubMed Web of Science ®Google Scholar
• Jarmer J, Zlatkovic J, Tsouchnikas G, et al. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol. 2014;88(23):13845–13857. doi:10.1128/JVI.02086-14
   PubMed Web of Science ®Google Scholar
• Veje M, Griška V, Pakalnienė J, et al. -Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients. Eur J Neurol. 2023 Oct;30(10):3182–3189. doi:10.1111/ene.15978
   PubMed Web of Science ®Google Scholar